Brown-Forman

BF-ANYSEUSD

THESIS ALERT

Email me when the BF-A thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$30.97
−$0.77 (−2.43%)Today 1M +17.95%
After hours$30.970.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$31.74
Prior regular-session close from the quote source.
$30.57–$31.27
Regular-session low and high so far today.
143.6K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$23.01–$32.32
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own BF-A if management sustains pricing/mix, executes cost savings, and avoids repeated brand impairments.

BF-A price history

Latest price$30.97Today−$0.77 (-2.43%)
BF-A +14.07%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

4 MATERIAL PROPOSITIONS
  • Brown-Forman's premium brand portfolio and pricing/mix ability will sustain high gross margins (protecting per-unit economics) even if volumes are pressured.StrengtheningMateriality: High

    Gross profit of $2,378,000,000 in FY2026 despite a modest revenue decline — implying high gross margin (~60% of revenue). If true, the company retains pricing power that preserves profitability and cash generation; if false, margin erosion will force trade-offs between marketing spend and returns or trigger impairments.

    Watch: A sustained consumer shift toward lower-priced spirits or aggressive premium campaigns by global competitors (e.g., Diageo/Pernod) that erode premium pricing.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Gross profit of $2,378,000,000 in FY2026 despite a modest revenue decline — implying high gross margin (~60% of revenue).

    Open source ↗
  • The restructuring initiative and working-capital actions will sustainably increase operating cash flow conversion, providing cash for reinvestment and shareholder returns.StrengtheningMateriality: High

    Operating cash flow rose to $1,000,000,000 in FY2026 from $598,000,000 in FY2025 and $647,000,000 in FY2024. Sustained higher cash conversion funds buybacks/dividends or brand investment without requiring dilutive transactions; if it reverses, reinvestment/shareholder returns will be constrained.

    Watch: Rising commodity, packaging, or logistics costs that offset restructuring savings.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating cash flow rose to $1,000,000,000 in FY2026 from $598,000,000 in FY2025 and $647,000,000 in FY2024.

    Open source ↗
  • Revenue recovery will depend on expanding premiumization and execution in international channels; without mix/price gains or restored growth in key markets, top-line will remain flat or decline.HoldingMateriality: Medium

    Company operates on six continents and positions itself in the premium-plus category (Item 1), providing channels for international premiumization. Top-line traction is the engine for long-term EPS growth; if premium mix and geographic expansion fail, earnings growth must come only from cost cuts or M&A.

    Watch: Currency headwinds (MD&A explicitly adjusts organic measures for forex) that depress reported sales even if local demand holds.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Company operates on six continents and positions itself in the premium-plus category (Item 1), providing channels for international premiumization.

    Open source ↗
  • Recurring brand impairments would indicate weaker long-term brand economics and presage lower pricing power and margins.HoldingMateriality: Medium

    MD&A documents non-cash impairment charges in fiscal 2025 and fiscal 2026 (Gin Mare and Diplomático) and these items impact operating results and net income. If impairments recur, management may need to write down goodwill/intangibles and future margins/returns will be structurally lower; if impairments stop, intangible asset values and future earnings are more secure.

    Watch: Management successfully integrates acquisitions and delivers market-share gains for acquired brands, avoiding future impairments.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    MD&A documents non-cash impairment charges in fiscal 2025 and fiscal 2026 (Gin Mare and Diplomático) and these items impact operating.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Brown-Forman's premium brand portfolio and pricing/mix ability will sustain high gross margins (protecting per-unit economics) even if volumes are pressured. If true, the company retains pricing power that preserves profitability and cash generation; if false, margin erosion will force trade-offs between marketing spend and returns or trigger impairments.

The restructuring initiative and working-capital actions will sustainably increase operating cash flow conversion, providing cash for reinvestment and shareholder returns. Sustained higher cash conversion funds buybacks/dividends or brand investment without requiring dilutive transactions; if it reverses, reinvestment/shareholder returns will be constrained.

Revenue recovery will depend on expanding premiumization and execution in international channels; without mix/price gains or restored growth in key markets, top-line will remain flat or decline. Top-line traction is the engine for long-term EPS growth; if premium mix and geographic expansion fail, earnings growth must come only from cost cuts or M&A.

Recurring brand impairments would indicate weaker long-term brand economics and presage lower pricing power and margins. If impairments recur, management may need to write down goodwill/intangibles and future margins/returns will be structurally lower; if impairments stop, intangible asset values and future earnings are more secure.

All standing thesis claims
Original report summary

management sustains pricing/mix, executes cost savings, and avoids repeated brand impairments.

Evidence assessed Nov 9, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Brown Forman

Where the evidence on Brown Forman stands: Holding on the latest evidence (Nov 9, 2026). Of its 4 thesis points, 2 strengthening and 2 holding.

Bull case: what the evidence supports

  • Brown-Forman's premium brand portfolio and pricing/mix ability will sustain high gross margins (protecting per-unit economics) even if volumes are pressured.

    sec.gov ↗

  • The restructuring initiative and working-capital actions will sustainably increase operating cash flow conversion, providing cash for reinvestment and shareholder returns.

    sec.gov ↗

  • Revenue recovery will depend on expanding premiumization and execution in international channels; without mix/price gains or restored growth in key markets, top-line will remain flat or decline.

    sec.gov ↗

  • Recurring brand impairments would indicate weaker long-term brand economics and presage lower pricing power and margins.

    sec.gov ↗

Bear case: what would count against it

  • A sustained consumer shift toward lower-priced spirits or aggressive premium campaigns by global competitors (e.g., Diageo/Pernod) that erode premium pricing.

    sec.gov ↗

  • Rising commodity, packaging, or logistics costs that offset restructuring savings.

    sec.gov ↗

  • Currency headwinds (MD&A explicitly adjusts organic measures for forex) that depress reported sales even if local demand holds.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Brown Forman

Loading the break-condition record for Brown Forman.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Entered a material definitive agreement.

    Brown Forman filed an SEC 8-K on 2026-09-21: Entered a material definitive agreement. It is a dated development that tests the current thesis.

  2. Mixed
    Reported results of operations (earnings release).

    Brown Forman filed an SEC 8-K on 2026-09-02: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  3. Mixed
    Regulation FD disclosure.

    Brown Forman filed an SEC 8-K on 2026-07-23: Regulation FD disclosure. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • A sustained consumer shift toward lower-priced spirits or aggressive premium campaigns by global competitors (e.g., Diageo/Pernod) that erode premium pricing.
  • Rising commodity, packaging, or logistics costs that offset restructuring savings.
  • Currency headwinds (MD&A explicitly adjusts organic measures for forex) that depress reported sales even if local demand holds.
  • Management successfully integrates acquisitions and delivers market-share gains for acquired brands, avoiding future impairments.

BF-A news

Loading headlines…

Financial statements

BF-A income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

BF-A: quick answers

What is BF-A's short interest?
As of October 30, 2026, 598,494 BF-A shares were sold short, down 6.0% from the count before. At the stock's average daily volume that is 5.0 days to cover. FINRA publishes the count twice a month. BF-A short interest history
Which well-known investors own BF-A?
1 of the 37 well-known funds tracked here reported BF-A shares in their latest 13F filing. By share of the fund's portfolio: Markel Group (Tom Gayner), 0.2%. Fund portfolios

BF-A in well-known investors’ portfolios

1 of 37 funds reported BF-A shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Tom GaynerMarkel Group0.18%$22.6MNo changeQ3 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.